09 January 2026 : Clinical Research
Baseline Tumor Biology Predicts Survival After Recurrence in Gastric Cancer: Impact of LVI, PNI, and HER2 Status
Gözde Ağdaş
ABCDE 1*, Mehmet Salim Demir AF 1
DOI: 10.12659/MSM.951829
Med Sci Monit 2026; 32:e951829
Table 3 Kaplan-Meier analysis of overall survival according to cTNM stage.
| OS (months) | 95% CI | P | ||
|---|---|---|---|---|
| cTNM stage | I | 92.8 | 64.3–121.3 | |
| II | 30.6 | 21.8–39.5 | ||
| III | 25.1 | 20.9–29.4 | ||
| Total | 38.9 | 29.9–47.8 | ||
| OS – overall survival; CI – confidence interval; cTNM – clinical tumor node metastasis stage. | ||||